Path Fertility

Path Fertility was honored to accept the Arkansas Business of the Year “Innovation Pacesetter Award” and we couldn’t be more grateful. For too long, male fertility has been sidelined, leaving women to shoulder the burden of unnecessary procedures, costs, and emotional distress. Arkansas recognizes this problem - and more importantly, supports innovative solutions. Thank you, Arkansas, for championing innovation and equity in fertility care. Together, we’re reshaping the path to parenthood. Andy Olson Kristin Brogaard, PhD Fuel Accelerator Arkansas Economic Development Commission Walton Family Foundation

Path Fertility is proud to provide community support & education through our monthly Fertility Speaker Series sessions. A special thank you to Sarah Felderhoff (UT-Dell) and Dr. Akua Afriyie-Gray (Dell Children’s) for educating us on the vital role of oncofertility and ovarian tissue cryopreservation. The latest advancements in fertility preservation are empowering more patients to take control of their reproductive health prior to undergoing cancer treatment. Thank you to Texas Fertility Center for this incredible opportunity! We are grateful for your partnership and support.

Path Fertility's Co-Founder and Chief Scientific Officer, Kristin Brogaard, PhD recently joined Robin Riddle on the "Explain This" podcast to discuss the need for deeper male fertility testing to create equity in the fertility journey. "When men go undiagnosed, women are put through fertility treatments that won't work - costing precious time, money, and emotional toll." A huge thank you to Robin Riddle for championing our mission to elevate the standard of care in male reproductive health, and for having us on the podcast to help spread the word!! ??? https://lnkd.in/gadxZwAG

A huge congratulations to our CEO, Andy Olson, for taking home first place in the pitch competition at the Virtual Life Science PitchForce! We're passionate about educating others and raising the bar in male fertility testing.

Did you catch Path Fertilty’s CEO, Andy Olson, presenting at the JPM BioTech Showcase in San Francisco yesterday? Thanks to all who were there to support us and our mission to raise the standard of care for male fertility testing. Because male infertility is a woman’s health issue!!!

Happy Holidays from your friends at Path Fertility! We are grateful to be working alongside the industry's finest to raise the standard of care in male reproductive health. Here's to a healthy and prosperous 2025!

SpermQT is different than DNA Fragmentation. DNA Fragmentation identifies chromosomal breaks and is recommended in cases of recurrent pregnancy loss, whereas SpermQT looks at methylation profiles that modify gene function and is most useful in the initial male fertility workup. SpermQT is a predictor of IUI success and measures the sperm's ability to find, bind, penetrate, and fertilize an egg. Learn more at https://lnkd.in/gjbDfiTi

SpermQT ("Sperm Quality Test") identifies subfertility missed by the standard semen analysis through examining DNA methylation patterns. The test allows fertility doctors and their patients to choose the right fertility treatment at the right time. Want to offer SpermQT to your patients? Connect with our Chief Scientific Officer here to learn more: https://lnkd.in/gpX5gptX

Curious about how SpermQT examines sperm gene function? Here’s a quick overview: Isolation: We separate sperm from somatic cells in the semen. Purification: Our gold-standard protocol, perfected over years, removes contaminating DNA. Extraction: Sperm DNA is carefully exposed through chemical processes for precise analysis. At Path Fertility, we’re proud to offer top-tier diagnostic accuracy, supporting better fertility outcomes. To learn more about SpermQT, visit our website here: https://pathfertility.com/.

?? Patient Story Highlight ?? We’re thrilled to share a testimonial from a patient in Nashville, Tennessee: "Finally getting an answer gave me a sense of control. It felt like a weight off of my shoulders to know what was going wrong after months of trying. SpermQT gave us such a sense of relief." SpermQT ("Sperm Quality Test") identifies subfertility missed by the standard semen analysis through examining DNA methylation patterns. To learn more about how you can offer SpermQT to your patients, click here to connect with our Chief Scientific Officer: https://lnkd.in/gpX5gptX